发现黑色素瘤发病的最小途径
Hui Xiao1, Jessica Shiu2, Chi-Fen Chen2
1Center for Complex Biological Systems, University of California, Irvine, USA.
Nature communications
|June 26, 2025
概括
黑色素瘤的发展只能发生在BRAF突变的情况下,这表明发生了随机事件. 皮肤中的神经状细胞作为黑色素瘤前体,提供诊断和治疗见解.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 黑色素瘤表现出遗传异质性,通常涉及基因激活蛋白激酶突变和瘤抑制基因丢失.
- 具有组合突变的小鼠模型会发展出快速生长的瘤,这与由于Braf激活和Pten丧失而导致的罕见缓慢生长的瘤不同.
研究的目的:
- 为了研究只有一种Braf突变的小鼠慢生长的黑色素瘤的起源.
- 识别导致黑色素瘤异质性的细胞前体.
主要方法:
- 在白化小鼠中诱导黑色素瘤,这些小鼠具有Braf突变.
- 对瘤发病率动力学和基因组稳定性的分析.
- 对瘤和正常皮肤的单细胞转录组分析.
- 鉴定细胞种群的基因表达分析.
主要成果:
- 缓慢生长的黑色素瘤可以在只具有Braf突变的小鼠中出现,其发病率动力学表明是一个随机事件.
- 没有发现新的突变或结构变异可以解释大多数瘤的发生.
- 在正常皮肤和瘤中发现了一种与神经状细胞相似的独特细胞群.
- 这些神经状细胞在布拉夫激活后扩大,并通过移植持续存在,作为恶性细胞前体.
结论:
- 一个Braf突变单独可以通过一个随机过程启动黑色素瘤的发展.
- 正常皮肤中的神经状细胞作为恶性黑色素瘤的前体.
- 这种前体状态代表了恶性瘤的缓慢途径,也是治疗向瘤异质性的潜在来源.
相关概念视频
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancers Originate from Somatic Mutations in a Single Cell
13.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.0K


